via MIT
A small, light-activated molecule recently tested in mice represents a new approach to eliminating clumps of amyloid protein found in the brains of Alzheimer’s disease patients. If perfected in humans, the technique could be used as an alternative approach to immunotherapy and used to treat other diseases caused by similar amyloids.
Researchers injected the molecule directly into the brains of live mice with Alzheimer’s disease and then used a specialized probe to shine light into their brains for 30 minutes each day for one week. Chemical analysis of the mouse brain tissue showed that the treatment significantly reduced amyloid protein. Results from additional experiments using human brain samples donated by Alzheimer’s disease patients supported the possibility of future use in humans.
“The importance of our study is developing this technique to target the amyloid protein to enhance clearance of it by the immune system,” said Yukiko Hori, a lecturer at the University of Tokyo and co-first author of the research recently published in Brain.
The small molecule that the research team developed is known as a photo-oxygenation catalyst. It appears to treat Alzheimer’s disease via a two-step process.
First, the catalyst destabilizes the amyloid plaques. Oxygenation, or adding oxygen atoms, can make a molecule unstable by changing the chemical bonds holding it together. Laundry detergents or other cleaners known as “oxygen bleach” use a similar chemical principle.
The catalyst is designed to target the folded structure of amyloid and likely works by cross-linking specific portions called histidine residues. The catalyst is inert until it is activated with near-infrared light, so in the future, researchers imagine that the catalyst could be delivered throughout the body by injection into the bloodstream and targeted to specific areas using light.
Second, the destabilized amyloid is then removed by microglia, immune cells of the brain that clear away damaged cells and debris outside healthy cells. Using mouse cells growing in a dish, researchers observed microglia engulfing oxygenated amyloid and then breaking it down in acidic compartments inside the cells.
“Our catalyst binds to the amyloid-specific structure, not to a unique genetic or amino acid sequence, so this same catalyst can be applied to other amyloid depositions,” said Professor Taisuke Tomita, who led the project at the University of Tokyo.
The American Society of Clinical Oncology estimates that each year in the U.S., 4,000 people are diagnosed with diseases caused by amyloid outside of the brain, collectively known as amyloidosis.
The photo-oxygenation catalyst should be capable of removing amyloid protein, regardless of when or where it formed in the body. Although some existing Alzheimer’s disease treatments can slow the formation of new amyloid plaques, eliminating existing plaques is especially important in Alzheimer’s disease because amyloid begins aggregating years before symptoms appear.
The research team is now working to modify the design of the catalyst so it can be activated by shining light through the skull.
Original Article: Power of light and oxygen clears Alzheimer’s disease protein in live mice
More from: University of Tokyo
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Reducing amyloid protein
- NKGen Biotech Presents Updated NK Cell Therapy Data for Neurodegenerative Disease at the 12th Annual Alzheimer's & Parkinson's Drug Development Summit
NKGen is a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic, and CAR-NK NK cell therapeutics. NKGen is headquartered in Santa ...
- What Is Amyloidosis?
Amyloidosis is a rare condition that develops when your body produces too many amyloid proteins, which can damage your organs and tissues.
- New Alzheimer’s Treatment Uses Light & X-Rays To Hit Harmful Protein
A new treatment for early-stage Alzheimer’s uses nanoparticles and light to slow the progress of the disease, set off by a low-powered x-ray.
- This Is The Reason Why People Living In Cities Are At Higher Risk Of Alzheimer’s Disease
In a study by the Emory Healthy Brain Study, researchers found a correlation between Alzheimer’s disease and people who were frequently exposed to ambient and traffic-related pollution. This study was ...
- AI connects gut bacteria metabolites to Alzheimer’s disease progression
A new study has discovered that metabolites from gut bacteria interact with specific human receptors, potentially influencing Alzheimer's disease. These findings could lead to novel therapies ...
Go deeper with Google Headlines on:
Reducing amyloid protein
[google_news title=”” keyword=”reducing amyloid protein” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Amyloidosis
- Two Paths for TREM2-Positive Microglia: DAM or Senescence?
In the April 18 Nature Neuroscience, researchers led by Michal Schwartz and Valery Krizhanovsky at the Weizmann Institute of Science, Rehovot, Israel, reported that some TREM2-positive microglia in an ...
- What Is Amyloidosis?
Amyloidosis is a rare condition that develops when your body produces too many amyloid proteins, which can damage your organs and tissues.
- What Is Amyloidosis?
She also writes stories covering public health, psychology, and women's issues. Amyloidosis is a rare protein-related condition that occurs when your body produces too many amyloid proteins ...
- Managing the Patient with Amyloidosis
It is important for the nurse to assess the extent of kidney involvement in amyloidosis and the development of the nephrotic syndrome. The nephrotic syndrome is suspected when there are high ...
- Professional Faqs: What Forms Of Amyloidosis Affect The Heart?
Expert opinion from Gustavo Campos Doctor of Medicine · 9 years of experience · Brazil Most amyloidosis type with cardiac involvement are caused by transthyretin amyloidosis (ATTR) or light chain ...
Go deeper with Google Headlines on:
Amyloidosis
[google_news title=”” keyword=”amyloidosis” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]